175 related articles for article (PubMed ID: 37516686)
1. Potential impact of obesity on the aggressiveness of low- to intermediate-risk papillary thyroid carcinoma: results from a MASTER cohort study.
Kim M; Kang YE; Park YJ; Koo BS; Ku EJ; Choi JY; Lee EK; Kim BH
Endocrine; 2023 Oct; 82(1):134-142. PubMed ID: 37516686
[TBL] [Abstract][Full Text] [Related]
2. Association of Body Mass Index With Clinicopathological Features of Papillary Thyroid Carcinoma: A Retrospective Study.
Dong Z; Liu W; Su F; Cheng R
Endocr Pract; 2023 Feb; 29(2):83-88. PubMed ID: 36481471
[TBL] [Abstract][Full Text] [Related]
3. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices.
Trésallet C; Seman M; Tissier F; Buffet C; Lupinacci RM; Vuarnesson H; Leenhardt L; Menegaux F
Surgery; 2014 Nov; 156(5):1145-52. PubMed ID: 24878452
[TBL] [Abstract][Full Text] [Related]
4. Obesity and High Risk Pathological Features of Papillary Thyroid Carcinoma: A Retrospective Analysis of a University Hospital in Pakistan.
Zaman SU; Awan MS; Sulaiman MA
Gulf J Oncolog; 2018 May; 1(27):6-10. PubMed ID: 30145545
[TBL] [Abstract][Full Text] [Related]
5. Influence of Body Mass Index on the Clinicopathologic Features of Papillary Thyroid Carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):625-632. PubMed ID: 30841713
[TBL] [Abstract][Full Text] [Related]
6. Influence of body mass index on the clinicopathological features of 13,995 papillary thyroid tumors.
Li CL; Dionigi G; Zhao YS; Liang N; Sun H
J Endocrinol Invest; 2020 Sep; 43(9):1283-1299. PubMed ID: 32166701
[TBL] [Abstract][Full Text] [Related]
7. Influence of Body Mass Index and Body Surface Area on the Behavior of Papillary Thyroid Carcinoma.
Kim SK; Woo JW; Park I; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2016 May; 26(5):657-66. PubMed ID: 26959390
[TBL] [Abstract][Full Text] [Related]
8. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
9. Association of obesity with the clinicopathological features of thyroid cancer in a large, operative population: A retrospective case-control study.
Zhao S; Jia X; Fan X; Zhao L; Pang P; Wang Y; Luo Y; Wang F; Yang G; Wang X; Gu W; Zang L; Pei Y; Du J; Ba J; Dou J; Mu Y; Lyu Z
Medicine (Baltimore); 2019 Dec; 98(50):e18213. PubMed ID: 31852078
[TBL] [Abstract][Full Text] [Related]
10. Associations between body mass index and lymph node metastases of patients with papillary thyroid cancer: A retrospective study.
Wu C; Wang L; Chen W; Zou S; Yang A
Medicine (Baltimore); 2017 Mar; 96(9):e6202. PubMed ID: 28248875
[TBL] [Abstract][Full Text] [Related]
11. Inverse Relationship of BMI to TSH and Risk of Papillary Thyroid Cancer in Surgical Patients.
Handelsman RS; Alvarez AL; Picado O; Farrá JC; Lew JI
J Surg Res; 2019 Dec; 244():96-101. PubMed ID: 31280000
[TBL] [Abstract][Full Text] [Related]
12. The relationship between subclinical hypothyroidism and invasive papillary thyroid cancer.
Li C; Zhang J; Dionigi G; Sun H
Front Endocrinol (Lausanne); 2023; 14():1294441. PubMed ID: 38174330
[TBL] [Abstract][Full Text] [Related]
13. Potential Impact of Body Mass Index on the Clinical Outcome of Papillary Thyroid Cancer After High-Dose Radioactive Iodine Therapy.
Cao J; Zhu X; Sun Y; Li X; Yun C; Zhang W
Front Endocrinol (Lausanne); 2022; 13():870530. PubMed ID: 35721759
[TBL] [Abstract][Full Text] [Related]
14. Radioactive iodine ablation may not decrease the risk of recurrence in intermediate-risk papillary thyroid carcinoma.
Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
Endocr Relat Cancer; 2016 May; 23(5):367-76. PubMed ID: 26917553
[TBL] [Abstract][Full Text] [Related]
15. Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies.
Xu L; Port M; Landi S; Gemignani F; Cipollini M; Elisei R; Goudeva L; Müller JA; Nerlich K; Pellegrini G; Reiners C; Romei C; Schwab R; Abend M; Sturgis EM
Thyroid; 2014 Jun; 24(6):966-74. PubMed ID: 24555500
[TBL] [Abstract][Full Text] [Related]
16. The Association Between Tumor Tissue Calcification, Obesity, and Thyroid Cancer Invasiveness In A Cohort Study.
Li C; Zhou L; Dionigi G; Li F; Zhao Y; Sun H
Endocr Pract; 2020 Aug; 26(8):830-839. PubMed ID: 33471674
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of Patients with 1-4 cm Papillary Thyroid Cancer Who Underwent Lobectomy: Focus on Gross Extrathyroidal Extension Invading Only the Strap Muscles.
Jang A; Jin M; Kim WW; Jeon MJ; Sung TY; Song DE; Kim TY; Chung KW; Kim WB; Shong YK; Lee YM; Kim WG
Ann Surg Oncol; 2022 Nov; 29(12):7835-7842. PubMed ID: 35907995
[TBL] [Abstract][Full Text] [Related]
18. Individualizing Surgery in Papillary Thyroid Carcinoma Based on a Detailed Sonographic Assessment of Extrathyroidal Extension.
Kuo EJ; Thi WJ; Zheng F; Zanocco KA; Livhits MJ; Yeh MW
Thyroid; 2017 Dec; 27(12):1544-1549. PubMed ID: 29113553
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of extrathyroidal extension according to primary tumor size in papillary thyroid carcinoma.
Liu L; Oh C; Heo JH; Park HS; Lee K; Chang JW; Jung SN; Koo BS
Eur J Surg Oncol; 2018 Nov; 44(11):1754-1759. PubMed ID: 29934055
[TBL] [Abstract][Full Text] [Related]
20. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer.
Kim HJ; Kim NK; Choi JH; Sohn SY; Kim SW; Jin SM; Jang HW; Suh S; Min YK; Chung JH; Kim SW
Clin Endocrinol (Oxf); 2013 Jan; 78(1):134-40. PubMed ID: 22812676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
